Sarepta Therapeutics Inc. (SRPT) on Wednesday reported second-quarter net income of $196.9 million. On a per-share basis, the ...

Shares of Sarepta Therapeutics (NASDAQ:SRPT) rose on Wednesday after the market as it reported second quarter revenue and ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...

After a second Elevidys patient death from acute liver failure, Sarepta in July launched a major restructuring that involves ...

The deadly crash of a medical transport plane on the Navajo Nation in northern Arizona has left the medical community in New ...